GWSG
MRTX

GPS Wealth Strategies Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

GPS Wealth Strategies Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5
Closed -$294 – 1320
2023
Q4 		$294 Hold
5
– – ﹤0.01% 1200
2023
Q3 		$218 Buy
+5
New +$179 ﹤0.01% 1240

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GPS Wealth Strategies Group's MRTX Position: Q1 2024 in Review

GPS Wealth Strategies Group sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 5 shares — an estimated $294 sold.

GPS Wealth Strategies Group first reported a position in MRTX in Q3 2023 and held it in 2 quarters. The position peaked at $294 in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • GPS Wealth Strategies Group reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 5 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $294.
  • GPS Wealth Strategies Group first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • GPS Wealth Strategies Group's Mirati Therapeutics, Inc. Common Stock position peaked at $294 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q1 2024, filed 30 Apr 2024.